Noopept, spatial memory and amyloid immunoreactivity after olfactory bulbectomy
Ostrovskaya RU, Gruden MA, Bobkova NA · 2007 · Journal of Psychopharmacology, online 2006, print 2007
Reported findings and study design
Noopept 0.01 mg/kg for 21 days plus five training days. Spatial memory was assessed with the Morris water maze and serum antibodies with ELISA.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Spatial memory | Improved in bulbectomized mice in the Morris water maze. | |
| Serum antibody response | Increased against amyloid-β(25–35) oligomers. Antibodies against equine lysozyme amyloid and S100b did not increase in bulbectomized mice. |
The abstract omits group sizes and a numerical behavioral effect size. The serum response does not quantify plaque clearance.
Source for these results ↗ · Reviewed 2026-11-12
For research and education. Consult a qualified clinician for medical advice.
Study limitations and source details
Study limitations
- The abstract omits group sizes and a numerical behavioral effect size. The serum response does not quantify plaque clearance.
Related publications may cover the same research program or participants.
Source access
Original abstract checked for selected methods and findings.
Source reviewed 2026-11-12.
Source type: Journal publication
Citation and original source
Original source: Ostrovskaya RU, Gruden MA, Bobkova NA. Noopept, spatial memory and amyloid immunoreactivity after olfactory bulbectomy Journal of Psychopharmacology, online 2006, print 2007 2007.
Molekul research summary: https://molekul.io/research/noopept-bulbectomy-2007. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry